Biopharmaceutical Company Silo Pharma Launches Cryptocurrency Fund Management Strategy
ChainCatcher reports that biopharmaceutical company Silo Pharma (NASDAQ: SILO) has announced the launch of a cryptocurrency fund management strategy and appointed crypto infrastructure expert Corwin Yu as the first member of its Cryptocurrency Advisory Board. The strategy will focus on major digital assets such as Bitcoin, Ethereum, and SOL.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CryptoQuant: Whales have deposited approximately $7.5 billion worth of BTC to a certain exchange in the past month
Today, BTC options with a notional value of $13 billion expire, with the max pain point at $98,000.
CME Group: BrokerTec EU market is now open for trading, all other markets remain suspended
Trending news
MoreCrypto prices
More
